Seventh Sense Biosystems has developed TAP, a device it says can quickly and painlessly draw blood for diagnostic testing. Photo courtesy of Seventh Sense.
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars